부산대학교 도서관

Yekedüz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.; Zarba M; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chehade REH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Steiner C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Machaalani M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ürün Y; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.; Heng DYC; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: toni_choueiri@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

In Urologic Oncology: Seminars and Original Investigations May 2014 32(4):512-513

In Urologic Oncology: Seminars and Original Investigations January 2013 31(1):127-128

In Urologic Oncology: Seminars and Original Investigations September-October 2012 30(5):746-747

In Urologic Oncology: Seminars and Original Investigations 2011 29(5):585-586

In Urologic Oncology: Seminars and Original Investigations 2011 29(5):583-584

In Urologic Oncology: Seminars and Original Investigations 2011 29(1):114-114

Xue H; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Kemp TJ; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Li C; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Roche NV; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Trowbridge R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Strauss S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Pinto LA; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Dang CM; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Kemp TJ; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Roche N; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Haynesworth K; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Loftus SA; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Borski BJ; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; El Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Trowbridge R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Strauss S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Pinto LA; Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

Lemelin A; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.; Maj D; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: David.Maj@AlbertaHealthServices.ca.; Takemura K; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Boyne DJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Warkentin MT; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Brenner DR; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Cheung WY; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Wells C; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Contreras LM; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.; Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.; Beuselinck B; Department of General Medical Oncology and Laboratory for Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; McKay RR; Department of Oncology, Moores Cancer Center, University of California San Diego, La Jolla, USA.; Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.; Yuasa T; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Ludwig L; Ipsen Biopharmaceuticals Canada, Inc., Mississauga, Canada.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Heng DYC; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Grubb T; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Koochaki P; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Matar S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Ghandour F; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Machaalani M; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Saad E; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Tang C; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reznik E; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Khatun J; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Salem C; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Dubasik N; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Orlando DA; Syros Pharmaceuticals Inc., Cambridge, MA, USA.; Guenther MG; Syros Pharmaceuticals Inc., Cambridge, MA, USA.; Parajuli G; Center for Immunotherapy and Precision Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.; Srivastava RM; Center for Immunotherapy and Precision Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.; Martinez SR; Center for Therapeutics Discovery, Cleveland Clinic, Cleveland, OH, USA.; Coker JA; Center for Therapeutics Discovery, Cleveland Clinic, Cleveland, OH, USA.; Kotecha RR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Hakimi AA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Asara JM; Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA, USA.; Chan TA; Center for Immunotherapy and Precision Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.; Vanharanta S; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Stauffer SR; Center for Therapeutics Discovery, Cleveland Clinic, Cleveland, OH, USA.; Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Chakraborty AA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. chakraa@ccf.org.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA. chakraa@ccf.org.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. chakraa@ccf.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Grivas, P; Khaki, AR; Wise-Draper, TM; French, B; Hennessy, C; Hsu, C-Y; Shyr, Y; Li, X; Choueiri, TK; Painter, CA; Peters, S; Rini, BI; Thompson, MA; Mishra, S; Rivera, DR; Acoba, JD; Abidi, MZ; Bakouny, Z; Bashir, B; Bekaii-Saab, T; Berg, S; Bernicker, EH; Bilen, MA; Bindal, P; Bishnoi, R; Bouganim, N; Bowles, DW; Cabal, A; Caimi, PF; Chism, DD; Crowell, J; Curran, C; Desai, A; Dixon, B; Doroshow, DB; Durbin, EB; Elkrief, A; Farmakiotis, D; Fazio, A; Fecher, LA; Flora, DB; Friese, CR; Fu, J; Gadgeel, SM; Galsky, MD; Gill, DM; Glover, MJ; Goyal, S; Grover, P; Gulati, S; Gupta, S; Halabi, S; Halfdanarson, TR; Halmos, B; Hausrath, DJ; Hawley, JE; Hsu, E; Huynh-Le, M; Hwang, C; Jani, C; Jayaraj, A; Johnson, DB; Kasi, A; Khan, H; Koshkin, VS; Kuderer, NM; Kwon, DH; Lammers, PE; Li, A; Loaiza-Bonilla, A; Low, CA; Lustberg, MB; Lyman, GH; McKay, RR; McNair, C; Menon, H; Mesa, RA; Mico, V; Mundt, D; Nagaraj, G; Nakasone, ES; Nakayama, J; Nizam, A; Nock, NL; Park, C; Patel, JM; Patel, KG; Peddi, P; Pennell, NA; Piper-Vallillo, AJ; Puc, M; Ravindranathan, D; Reeves, ME; Reuben, DY; Rosenstein, L; Rosovsky, RP; Rubinstein, SM; Salazar, M; Schmidt, AL; Schwartz, GK

Annals of Oncology. 32(6)

Liu F; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Tarannum M; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Zhao Y; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Zhang YJ; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ham JD; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Lei K; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Qiang Y; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Deng X; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Nguyen M; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Dinh K; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Yang S; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ali AK; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Choueiri TK; Division of Genitourinary Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ritz J; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Romee R; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. rizwan_romee@dfci.harvard.edu.; Chen J; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. jchen@mit.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Eid S; Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Al-Yousef AS; Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Kim KW; Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Radiology, Asan Medical Center, Asan Image Metrics, University of Ulsan College of Medicine, Seoul, Republic of Korea. kyungwon.kim@aim-aicro.com.; Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Nawfal R; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Krajewski KM; Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Publisher: Korean Society of Radiology Country of Publication: Korea (South) NLM ID: 100956096 Publication Model: Print Cited Medium: Internet ISSN: 2005-8330 (Electronic) Linking ISSN: 12296929 NLM ISO Abbreviation: Korean J Radiol Subsets: MEDLINE

Yadav M; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, Delhi, India.; Laboratory of Nanotechnology and Chemical Biology, Regional Center for Biotechnology, Faridabad, Haryana, India.; Sharma A; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, USA.; Patne K; Chromatin Remodeling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.; Tabasum S; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Suryavanshi J; Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA.; Rawat L; Harvard Medical School, Boston, MA, USA.; Division of Nephrology, Boston Children's Hospital, Boston, MA, USA.; Machaalani M; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Eid M; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Singh RP; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, Delhi, India.; Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Pal S; Harvard Medical School, Boston, MA, USA. soumitro.pal@childrens.harvard.edu.; Division of Nephrology, Boston Children's Hospital, Boston, MA, USA. soumitro.pal@childrens.harvard.edu.; Sabarwal A; Harvard Medical School, Boston, MA, USA. akash.sabarwal@childrens.harvard.edu.; Division of Nephrology, Boston Children's Hospital, Boston, MA, USA. akash.sabarwal@childrens.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Jay, Raman; McKay, RR; Werner, L; Atkins, MB; Van Allen, EM; Olivier, KM; Song, J; Signoretti, S; McDermott, DF; Choueiri, TK

In Urologic Oncology: Seminars and Original Investigations March 2017 35(3):117-118

Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Siegmund SE; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Wu SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El Hajj Chehade R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Gulati GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Phillips N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; French CA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Jacene HA; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, USA.; Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. sylvan_baca@dfci.harvard.edu.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jberchuck@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, USA. jberchuck@emory.edu.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA. jberchuck@emory.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Venkadakrishnan VB; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Bakht MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Sigouros M; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Chan J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Trigos A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.; Driskill JH; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Manohar J; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; King A; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Presser AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Kim MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Quigley D; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Urology, University of California San Francisco, San Francisco, CA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Balk S; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Hill S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Mosquera JM; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Einstein D; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Fletcher K; Vanderbilt University School of Medicine, Nashville, Tennessee.; Machaalani M; Dana Farber Cancer Institute, Boston, Massachusetts.; El Hajj Chehade R; Dana Farber Cancer Institute, Boston, Massachusetts.; Nassar AH; Yale University, New Haven, Connecticut.; Nawfal R; Dana Farber Cancer Institute, Boston, Massachusetts.; Manos M; Dana Farber Cancer Institute, Boston, Massachusetts.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Aboubakar-Nana F; Service de Pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Hassel JC; University Hospital Heidelberg, Heidelberg, Germany.; Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine (DIMET), University of Piemonte Orientale, Novara, Italy.; Johnson A; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.; Olsson-Brown AC; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Westmead and Blacktown Hospitals, Sydney, New South Wales Australia.; Malgeri A; Fondazione Policlinico Universitario Campus-Biomedico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Fondazione Policlinico Universitario Campus-Biomedico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Singh A; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Parikh K; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Kim SY; Yale University, New Haven, Connecticut.; Naqash AR; Medical Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences, Oklahoma City.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Challa P; Yale University, New Haven, Connecticut.; Choueiri TK; Dana Farber Cancer Institute, Boston, Massachusetts.; Sharon E; Dana Farber Cancer Institute, Boston, Massachusetts.; Shah S; Department of Neurology, Northwestern University, Chicago, Illinois.; Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.; Johnson DB; Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

McGregor BA; Dana Farber Cancer Institute, Boston MA. Electronic address: Bradley_mcgregor@dfci.harvard.edu.; Xie W; Dana Farber Cancer Institute, Boston MA.; Berg SA; Dana Farber Cancer Institute, Boston MA.; Xu W; Dana Farber Cancer Institute, Boston MA.; Viswanathan SR; Dana Farber Cancer Institute, Boston MA.; McDermott D; Beth Israel Deaconess Medical Center, Boston MA.; Signoretti S; Brigham and Women's Hospital, Boston MA.; Kaelin WG Jr; Dana Farber Cancer Institute, Boston MA.; Choueiri TK; Dana Farber Cancer Institute, Boston MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE